Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical General Factory, has received approval from the National Medical Products Administration for its Azithromycin Capsule, which has passed the generic drug quality and therapeutic consistency evaluation. This approval marks a significant milestone for the company, ensuring that their generic drug meets the required standards for quality and efficacy.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
